411 related articles for article (PubMed ID: 19614769)
1. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate.
Mühleisen B; Petrov I; Gächter T; Kurrer M; Schärer L; Dummer R; French LE; Hofbauer GF
Histopathology; 2009 Jul; 55(1):67-76. PubMed ID: 19614769
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
3. Pronounced allelic imbalance at D9S162 in skin squamous cell carcinoma of organ transplant recipients.
Mühleisen B; Petrov I; Frigerio S; Dziunycz P; French LE; Hofbauer GF
Arch Dermatol; 2012 Jun; 148(6):697-703. PubMed ID: 22508773
[TBL] [Abstract][Full Text] [Related]
4. Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients.
Krynitz B; Lundh Rozell B; Lindelöf B
Acta Derm Venereol; 2010 Jul; 90(4):379-85. PubMed ID: 20574603
[TBL] [Abstract][Full Text] [Related]
5. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.
Azzimonti B; Zavattaro E; Provasi M; Vidali M; Conca A; Catalano E; Rimondini L; Colombo E; Valente G
Br J Dermatol; 2015 Jan; 172(1):64-73. PubMed ID: 24910265
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Hiraoka N; Onozato K; Kosuge T; Hirohashi S
Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
[TBL] [Abstract][Full Text] [Related]
7. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
[TBL] [Abstract][Full Text] [Related]
8. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
Satchell AC; Barnetson RS; Halliday GM
Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort with regard to tumor site.
Lindelöf B; Dal H; Wolk K; Malmborg N
Arch Dermatol; 2005 Apr; 141(4):447-51. PubMed ID: 15837862
[TBL] [Abstract][Full Text] [Related]
10. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
Dziunycz P; Hofbauer GF
Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype of skin lymphocytic infiltrate in patients co-infected with Mycobacterium leprae and human immunodeficiency virus: a scenario dependent on CD8+ and/or CD20+ cells.
Massone C; Talhari C; Talhari S; Brunasso AM; Campbell TM; Curcic P; Cerroni L; Ribeiro-Rodrigues R
Br J Dermatol; 2011 Aug; 165(2):321-8. PubMed ID: 21574977
[TBL] [Abstract][Full Text] [Related]
13. Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients.
Drake AL; Walling HW
J Am Acad Dermatol; 2008 Jul; 59(1):68-71. PubMed ID: 18440666
[TBL] [Abstract][Full Text] [Related]
14. Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients.
Muehleisen B; Schaerer L; Dummer R; Burg G; Hofbauer GF
J Cutan Pathol; 2007 Jan; 34(1):1-6. PubMed ID: 17214847
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
Fraga GR; Chow P
J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tumor-infiltrating lymphocytes in cutaneous squamous cell carcinoma.
Haeffner AC; Zepter K; Elmets CA; Wood GS
Arch Dermatol; 1997 May; 133(5):585-90. PubMed ID: 9158411
[TBL] [Abstract][Full Text] [Related]
17. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.
Carucci JA; Martinez JC; Zeitouni NC; Christenson L; Coldiron B; Zweibel S; Otley CC
Dermatol Surg; 2004 Apr; 30(4 Pt 2):651-5. PubMed ID: 15061850
[TBL] [Abstract][Full Text] [Related]
18. Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls.
Sandvik LF; Skarstein K; Krynitz B; Volchenkov R; Sviland L; Leivestad T; Jonsson R; Appel S
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2128-35. PubMed ID: 25845701
[TBL] [Abstract][Full Text] [Related]
19. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
20. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
